<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00819871</url>
  </required_header>
  <id_info>
    <org_study_id>PCSP-NFKB1</org_study_id>
    <nct_id>NCT00819871</nct_id>
  </id_info>
  <brief_title>Nuclear Factor Kappa-B (NFKB1) Polymorphism and Organ Injury After Cardiac Surgery</brief_title>
  <official_title>Association of NFKB1 -94 Polymorphism With Lung and/or Kidney Injury After Cardiac Surgery With Cardiopulmonary Bypass</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changhai Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Changhai Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      NFKB1 -94ins/del polymorphism has been reported to be associated with reduced promoter
      activity of NFKB1 and several clinical diseases, but the clinical results cannot always be
      replicated. Besides, mutate allele is associated with alleviated inflammation in ulcerative
      colitis and some tumors, but aggravated inflammation in ARDS. The clinical value of this
      polymorphism remains controversial. This study was performed to investigate the association
      of NFKB1 -94ins/delATTG polymorphism with lung and/or kidney injury after cardiac surgery
      with CPB.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>lung injury and/or kidney injury after cardiac surgery with cardiopulmonary bypass</measure>
    <time_frame>24h after cardiac surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>circulating level of CRP, TNF-alpha, IL-10; APACHE Ⅱ score; duration of ICU stay and hospitalization; death in 28 days</measure>
    <time_frame>one month after cardiac surgery</time_frame>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">105</enrollment>
  <condition>Single Nucleotide Polymorphism</condition>
  <condition>Acute Lung Injury</condition>
  <condition>Kidney Injury</condition>
  <arm_group>
    <arm_group_label>PLI</arm_group_label>
    <description>patients with postoperative lung injury</description>
  </arm_group>
  <arm_group>
    <arm_group_label>without PLI</arm_group_label>
    <description>patients without postoperative lung injury</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PLI/PKI</arm_group_label>
    <description>patients with at least one organ injury of lung or kidney after surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>without PLI/PKI</arm_group_label>
    <description>patients without lung or kidney injury after surgery</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      3ml blood before surgery, after surgery and 24h after surgery respectively
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Chinese Han patients undergoing elective cardiac surgery with CPB
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chinese Han unrelated population

          -  undergoing elective cardiac surgery with CPB

        Exclusion Criteria:

          -  malignant tumor

          -  autoimmune disease, immunodeficiency or immunosuppressive therapy

          -  chronic renal disease (glomerular filtration rate &lt; 60ml/(min•1.73m2)) or liver
             dysfunction (Child Pugh classification&gt;A)

          -  COPD, tuberculosis or other chronic pulmonary diseases

          -  anemia with hemoglobin lower than 90mmHg

          -  bleeding disorders

          -  postoperative pericardial tamponade requiring re-operation

          -  postoperative low cardiac output syndrome or acute pulmonary edema after left cardiac
             failure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Changhai Hospital, Second Military Medical University</name>
      <address>
        <city>Shanghai</city>
        <zip>200433</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Wang JF, Bian JJ, Wan XJ, Zhu KM, Sun ZZ, Lu AD. NFKB1-94ins/del polymorphism is not associated with lung injury after cardiopulmonary bypass. Anaesthesia. 2010 Feb;65(2):158-62. doi: 10.1111/j.1365-2044.2009.06186.x. Epub 2009 Nov 25.</citation>
    <PMID>19995347</PMID>
  </results_reference>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 8, 2009</study_first_submitted>
  <study_first_submitted_qc>January 8, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 9, 2009</study_first_posted>
  <last_update_submitted>May 2, 2013</last_update_submitted>
  <last_update_submitted_qc>May 2, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 3, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Changhai Hospital</investigator_affiliation>
    <investigator_full_name>Jia-feng Wang</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Lung Injury</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

